Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division Sort descending
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Sort descending Business Functional Area Erscheinungsdatum
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Senior Scientist I/II, Immunology– Immunogenicity and Mechanistic Immunology group Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 18, 2024
Senior Scientist - Target Biology and Discovery Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Okt 18, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Director of Global & Swiss Media & Editorial Basel (City) Schweiz Corporate CTS Communications & Public Affairs Okt 18, 2024
Manager, Post Production & Video Services Hyderabad (Office) Indien Corporate Affairs CTS Communications & Public Affairs Okt 04, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Patient Engagement Lead İstanbul Kavacık Türkei Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Chef, Communications corporatives Montreal Kanada Corporate Affairs CTS Communications & Public Affairs Okt 21, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Schweiz Corporate Affairs Corporate BD&L & Strategic Planning Okt 15, 2024
Comms & Engagement Manager Amsterdam Niederlande Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Director of Commercial Policy Communications and Media Relations, Europe Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 24, 2024
Manager, Corporate Communications Montreal Kanada Corporate Affairs CTS Communications & Public Affairs Okt 21, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Okt 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Okt 22, 2024
Government Affairs Manager Moscow (City) Russische Foed. Corporate Affairs Innovative Medicines Communications & Public Affairs Okt 22, 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs Okt 22, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Corporate Affairs Innovative Medicines Einrichtungen und Verwaltung Sep 02, 2024
SSO Finance Specialist İstanbul Kavacık Türkei Development Innovative Medicines Research & Development Sep 10, 2024
RA Manager, Procedural Documents London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 10, 2024
RA GDD Project Specialist London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Einrichtungen und Verwaltung Sep 10, 2024
Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 11, 2024
Senior Regulatory Affairs Manager Vietnam Vietnam Development Innovative Medicines Research & Development Okt 22, 2024
Head, Clinical Development Strategy & Integration Lead Basel (City) Schweiz Development Innovative Medicines Research & Development Sep 12, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
Associate Director- Clinical Data Standards Mumbai (Office) Indien Development Innovative Medicines Research & Development Sep 13, 2024
Senior Global Risk Management Plan Manager Barcelona Gran Vía Spanien Development Innovative Medicines Research & Development Sep 16, 2024
Principal Biostatistician Home Worker Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 17, 2024
Director Quantitative Safety Scientist Dublin (Novartis Corporate Center (NOCC)) Irland Development Innovative Medicines Research & Development Sep 17, 2024
Global Labelling Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 17, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) China Development Innovative Medicines Research & Development Sep 17, 2024
Expert Science & Technology II- Analytical Research & Development Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Sep 18, 2024
Global Program Clinical Head: In-market Brands London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Research & Development Sep 18, 2024
Senior Expert, Science & Technology - Potency East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Executive Director, Global Operational Excellence East Hanover USA Development Innovative Medicines Research & Development Sep 18, 2024
Senior Principal Statistical Programmer - Advanced Quantitative Sciences East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Associate Director, Statistical Programming East Hanover USA Development Innovative Medicines Research & Development Sep 19, 2024
Clinical Development Medical Director - Renal **80-100% Basel (City) Schweiz Development Innovative Medicines Research & Development Sep 20, 2024
Global Program Clinical Head - CRM Basel (City) Schweiz Development Innovative Medicines Research & Development Sep 20, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Sep 24, 2024
Associate Director Strategy and Operations Hyderabad (Office) Indien Development Innovative Medicines Research & Development Sep 24, 2024
Senior Principal Biostatistician Hyderabad (Office) Indien Development Innovative Medicines Research & Development Okt 03, 2024
Lead, Capability Learning Solutions Hyderabad (Office) Indien Development Innovative Medicines Humanressourcen Okt 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.